Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Fundamentals
Mkt Cap
$353.48M
Volume
-
52W High
$13.25
52W Low
$5.65
PE Ratio
-78.69
Avg. Volume
194,860.63
EPS (Annual)
-$0.3409
P/B
8.32
Rev/Employee
$1,275,485.71
Earnings
Nov 12
33
Bearish Sentiment
How do you feel about FENC?
kwagz
$FENC Still here and adding. This one should run soon imo. Next earnings and updates on adult trials will fuel it further.